B cell synovitis and clinical phenotypes in rheumatoid arthritis: relationship to disease stages and drug exposure by Humby, F, Bugatti, S, Fossati-Jimack, L, Rizvi, H, Lucchesi, D, Lliso-Ribera, G, Nerviani, A, Hands, RE, Giorli, G, Frias, B, Thorborn, G, Jaworska, E, John, C, Goldmann, K, Lewis, MJ, Manzo, A, Bombardieri, M, Pitzalis, C, PEAC-R4RA Investigators

Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial by Rivellese, F, Surace, AEA, Goldmann, K, Sciacca, E, Çubuk, C, Giorli, G, John, CR, Nerviani, A, Fossati-Jimack, L, Thorborn, G, Ahmed, M, Prediletto, E, Church, SE, Hudson, BM, Warren, SE, McKeigue, PM, Humby, F, Bombardieri, M, Barnes, MR, Lewis, MJ, Pitzalis, C